BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-323@pharmaconomics
DTSTAMP:20260707T003608Z
DTSTART;VALUE=DATE:20260829
DTEND;VALUE=DATE:20260830
SUMMARY:TENX Phase 3 — TNX-103
DESCRIPTION:Phase 3 trial results for TNX-103 in PH-HFpEF are due Aug 29\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/34956/000119312526293485/d20457dex991.htm\n\nTrack it: https://pharmaconomics.com/e/323
URL:https://pharmaconomics.com/e/323
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TENX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR